India, June 11 -- image credit- shutterstock

US-based ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, has announced that Immuneel Therapeutics has been awarded a$150,000G-Rex grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing inIndia.

"The blood cancer burden onIndia'spopulation is substantial, around 120,000 new cases of lymphoma, leukemia, and multiple myeloma are diagnosed each year. Unfortunately, almost 70,000 Indians will die every year from these afflictions, devastating the lives of their families and communities. To afford access to all Indian patients in need, and to capitalise on the immense commercial po...